Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy.
NPJ Precis Oncol. 2022 Mar 31;6(1):19. doi: 10.1038/s41698-022-00262-y.
NPJ Precis Oncol. 2022.
PMID: 35361874
Free PMC article.
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.
Daniello L, Elshiaty M, Bozorgmehr F, Kuon J, Kazdal D, Schindler H, Shah R, Volckmar AL, Lusky F, Diekmann L, Liersch S, Faehling M, Muley T, Kriegsmann M, Benesova K, Stenzinger A, Thomas M, Christopoulos P.
Daniello L, et al. Among authors: lusky f.
Front Oncol. 2021 Jun 29;11:703893. doi: 10.3389/fonc.2021.703893. eCollection 2021.
Front Oncol. 2021.
PMID: 34268127
Free PMC article.
Item in Clipboard
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.
Schindler H, Lusky F, Daniello L, Elshiaty M, Gaissmaier L, Benesova K, Souto-Carneiro M, Angeles AK, Janke F, Eichhorn F, Kazdal D, Schneider M, Liersch S, Klemm S, Schnitzler P, Stenzinger A, Sültmann H, Thomas M, Christopoulos P.
Schindler H, et al. Among authors: lusky f.
Front Oncol. 2022 Oct 31;12:1010660. doi: 10.3389/fonc.2022.1010660. eCollection 2022.
Front Oncol. 2022.
PMID: 36387148
Free PMC article.
Item in Clipboard
Cite
Cite